Skip to content

Effect of MS14 on multiple sclerosis

Effect of MS14, an herbal marine drug on physical activity improvement in patients with multiple sclerosis; a double blind, placebo controlled study

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20161203031205N3
Enrollment
100
Registered
2018-04-18
Start date
2018-02-04
Completion date
Unknown
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis. Multiple sclerosis

Interventions

Intervention 1: Intervention group: They will recieve MS14, 50 milligram for each kilogram of body weight daily in the form of caplet for 3 weeks. MS14, a natural product will be made mainly from Pena

Sponsors

Shahed University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Fulfill MS diagnosis criteria Minimum age of 18 years Problems in walking Ability to walk more than 5 meters with or without helping Disease condition should be stable during past 6 months

Exclusion criteria

Exclusion criteria: Cardiovascular diseases Pregnancy Disease relapse during the trial Having active and known infection Like to use another new drug effective on patient's syptoms Major cognitive disorder or psychotic disease Advanced movement disorder like fixed tendon contracture Abnormality in blood test in beginning of the study Major depression Using other drugs effective in movement Using other natural remedies

Design outcomes

Primary

MeasureTime frame
Transportation physical activity. Timepoint: Before and 3 weeks after intervention. Method of measurement: International physical activity questionnaire.;Moderate physical activity. Timepoint: Before and 3 weeks after intervention. Method of measurement: International physical activity questionnaire.;Total physical activity index. Timepoint: Before and 3 weeks after intervention. Method of measurement: International physical activity questionnaire.

Secondary

MeasureTime frame
Fatigue severity. Timepoint: Before and 3 weeks after the intervention. Method of measurement: Fatigue severity scale.;Timed 10 meter walk. Timepoint: Before and 3 weeks after intervention. Method of measurement: measuring the time needed for 10 meter walk.;Spasticity severity. Timepoint: Before and 3 weeks after the intervention. Method of measurement: Ashworth scale.;Timed get up and go. Timepoint: Before and 3 weeks after intervention. Method of measurement: measuring the time needed from getting up until initiating the activity.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Naseri

Shahed University

naserishahed1395@gmail.com+98 21 6646 4420

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026